COMSTOCK RESOURCES INC (CRK) Stock Fundamental Analysis
NYSE:CRK - New York Stock Exchange, Inc. - US2057683029 - Common Stock - Currency: USD
Overall CRK gets a fundamental rating of 2 out of 10. We evaluated CRK against 213 industry peers in the Oil, Gas & Consumable Fuels industry. CRK has a bad profitability rating. Also its financial health evaluation is rather negative. CRK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CRK had negative earnings in the past year.
In the past year CRK had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CRK reported negative net income in multiple years.
In the past 5 years CRK always reported a positive cash flow from operatings.
1.2 Ratios
CRK has a Return On Assets of -5.07%. This is in the lower half of the industry: CRK underperforms 77.46% of its industry peers.
With a Return On Equity value of -15.77%, CRK is not doing good in the industry: 77.93% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.07% | ||
| ROE | -15.77% | ||
| ROIC | N/A |
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of CRK (55.07%) is better than 62.44% of its industry peers.
CRK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CRK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.07% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
2. Health
2.1 Basic Checks
CRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRK has more shares outstanding than it did 1 year ago.
CRK has more shares outstanding than it did 5 years ago.
CRK has a worse debt/assets ratio than last year.
2.2 Solvency
CRK has an Altman-Z score of 1.24. This is a bad value and indicates that CRK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRK (1.24) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that CRK has dependencies on debt financing.
With a Debt to Equity ratio value of 1.44, CRK is not doing good in the industry: 75.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.24 |
ROIC/WACCN/A
WACC8.17%
2.3 Liquidity
CRK has a Current Ratio of 0.40. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
CRK's Current ratio of 0.40 is on the low side compared to the rest of the industry. CRK is outperformed by 91.55% of its industry peers.
CRK has a Quick Ratio of 0.40. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CRK (0.40) is worse than 88.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
CRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -127.27%.
The Revenue for CRK has decreased by -24.74% in the past year. This is quite bad
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)-127.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%52.74%
3.2 Future
CRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 105.48% yearly.
CRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.42% yearly.
EPS Next Y419.68%
EPS Next 2Y168.36%
EPS Next 3Y96.99%
EPS Next 5Y105.48%
Revenue Next Year47.29%
Revenue Next 2Y30.68%
Revenue Next 3Y21.42%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CRK. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 20.29 indicates a rather expensive valuation of CRK.
Based on the Price/Forward Earnings ratio, CRK is valued a bit more expensive than 60.09% of the companies in the same industry.
CRK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.29 |
4.2 Price Multiples
CRK's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CRK is more expensive than 62.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.18 |
4.3 Compensation for Growth
CRK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRK's earnings are expected to grow with 96.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y168.36%
EPS Next 3Y96.99%
5. Dividend
5.1 Amount
CRK has a Yearly Dividend Yield of 4.74%, which is a nice return.
Compared to an average industry Dividend Yield of 6.74, CRK pays a bit more dividend than its industry peers.
CRK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.74% |
5.2 History
CRK has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y168.36%
EPS Next 3Y96.99%
25.33
-0.29 (-1.13%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners30.67%
Inst Owner Change-2.99%
Ins Owners2.17%
Ins Owner Change0.18%
Market Cap7.42B
Analysts53.91
Price Target20.4 (-19.46%)
Short Float %27.05%
Short Ratio8.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.74% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)282.75%
Min EPS beat(2)14.38%
Max EPS beat(2)551.11%
EPS beat(4)2
Avg EPS beat(4)134.58%
Min EPS beat(4)-22.17%
Max EPS beat(4)551.11%
EPS beat(8)3
Avg EPS beat(8)57.37%
EPS beat(12)5
Avg EPS beat(12)40.14%
EPS beat(16)7
Avg EPS beat(16)30.61%
Revenue beat(2)1
Avg Revenue beat(2)8.81%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)20.2%
Revenue beat(4)1
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-17.72%
Max Revenue beat(4)20.2%
Revenue beat(8)3
Avg Revenue beat(8)-1.61%
Revenue beat(12)7
Avg Revenue beat(12)20.57%
Revenue beat(16)11
Avg Revenue beat(16)21.28%
PT rev (1m)7.14%
PT rev (3m)16.67%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)52.86%
EPS NY rev (1m)-2.96%
EPS NY rev (3m)9.79%
Revenue NQ rev (1m)2.85%
Revenue NQ rev (3m)7.54%
Revenue NY rev (1m)4.91%
Revenue NY rev (3m)9.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.29 | ||
| P/S | 5.19 | ||
| P/FCF | N/A | ||
| P/OCF | 11.9 | ||
| P/B | 3.5 | ||
| P/tB | 4.16 | ||
| EV/EBITDA | 14.18 |
EPS(TTM)-0.03
EYN/A
EPS(NY)1.25
Fwd EY4.93%
FCF(TTM)-1.44
FCFYN/A
OCF(TTM)2.13
OCFY8.4%
SpS4.88
BVpS7.24
TBVpS6.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.07% | ||
| ROE | -15.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 55.07% | ||
| FCFM | N/A |
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
F-Score2
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 135.13% | ||
| Cap/Sales | 72.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 84.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 | ||
| Altman-Z | 1.24 |
F-Score2
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)196.86%
Cap/Depr(5y)171.92%
Cap/Sales(3y)69.34%
Cap/Sales(5y)60.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y419.68%
EPS Next 2Y168.36%
EPS Next 3Y96.99%
EPS Next 5Y105.48%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%52.74%
Revenue Next Year47.29%
Revenue Next 2Y30.68%
Revenue Next 3Y21.42%
Revenue Next 5YN/A
EBIT growth 1Y-114.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2445.91%
EBIT Next 3Y221.93%
EBIT Next 5Y145.7%
FCF growth 1Y-173.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.37%
OCF growth 3Y-10.28%
OCF growth 5Y6.57%